Connect to other sites within the UBM Medica Network
Beyond Zika: 7 Things Rheumatologists Should Know About Chikungunya
With the spread of Zika virus rating as a "public health emergency" by the World Health Organization, another emerging mosquito-borne illness is worrying rheumatologists: chikungunya.
"No Safe Dose in Glucocorticoids"
Eric Morand, M.D., Ph.D., Director of Rheumatology at Monash Health in Australia, speaks with Rheumatology Network about his recent article in Nature Reviews Rheumatology.
Vitamin D Changes the Tide in Rheumatoid Arthritis
Severe vitamin D deficiency could be responsible for persistent rheumatoid arthritis disease activity.
Breathless with Rheumatoid Arthritis: A Case of ILD
This is a case report of a patient with rheumatoid arthritis in whom interstitial lung disease (ILD) developed. ILD is one of several pulmonary complications of RA.
New IL-6 Blocker Holds Promise for RA
Clazakizumab, with or without methotrexate, was well tolerated and achieved significant improvements in disease activity, in patients with rheumatoid arthritis in this Phase IIb study.
Hand deformities seen in Jaccoud's arthropathy are the result of soft-tissue abnormalities, not the destruction of bone joints seen in rheumatoid arthritis.
Certolizumab-MTX Combo May Help Early RA Patients with Poor Prognosis
Responses to the combination therapy in this phase 3 clinical trial were seen as early as one week into the study.
By clicking Accept, you agree to become a member of the UBM Medica Community.